Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE ...

Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

Scorpius Holdings, Inc. has announced a collaboration with KaloCyte to improve the manufacturing efficiency of KaloCyte's lead product, ErythroMer™, a bio-engineered artificial red blood cell ...

Scorpius announced its collaboration with KaloCyte. Under this initial project, Scorpius will utilize its scientific and technical expertise to ...

Scorpius Holdings, Inc (NYSE American: SCPX) ("Scorpius" or "the Company"), an integrated contract development and manufacturing organization ("CDMO") ...

ThunderCats: Lost #2 introduces Scorpius, a formidable new foe for the ThunderCats. Bengali, Pumyra, and Lynx-O make a return ...

Scorpius BioManufacturing officials on Thursday told The Mercury the original deal they made with the state to construct a $650-million, 500,000-square-foot vaccine and biologic medicine plant is ...